Yale Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06520.
Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.
Yale Cancer Center has participated in 313 clinical trials with 117 currently active.
Therapeutic areas: HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
Sponsors: Seagen Inc., BeOne Medicines, Joseph Paul Eder.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Connecticut · View every site in New Haven
Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Yale Cancer Center has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Yale Cancer Center has 313 clinical trials on record, with 117 currently active. Their work covers HER2 Positive Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Triple Negative Breast Neoplasms.
Yale Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.